Protara Therapeutics Inc [NASDAQ: TARA] price surged by 70.06 percent to reach at $2.48.
The one-year TARA stock forecast points to a potential upside of 77.2. The average equity rating for TARA stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Protara Therapeutics Inc [TARA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TARA shares is $26.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TARA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Protara Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 10, 2023. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on June 04, 2021, representing the official price target for Protara Therapeutics Inc stock. Previously, the target price had yet another raise to $43, while Oppenheimer analysts kept a Outperform rating on TARA stock.
The Average True Range (ATR) for Protara Therapeutics Inc is set at 0.76 The Price to Book ratio for the last quarter was 1.52, with the Price to Cash per share for the same quarter was set at 3.95.
TARA Stock Performance Analysis:
Protara Therapeutics Inc [TARA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 98.03. With this latest performance, TARA shares gained by 130.65% in over the last four-week period, additionally plugging by 122.14% over the last 6 months – not to mention a rise of 330.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TARA stock in for the last two-week period is set at 86.14, with the RSI for the last a single of trading hit 88.81, and the three-weeks RSI is set at 83.78 for Protara Therapeutics Inc [TARA]. The present Moving Average for the last 50 days of trading for this stock 2.32, while it was recorded at 3.58 for the last single week of trading, and 2.66 for the last 200 days.
Insight into Protara Therapeutics Inc Fundamentals:
Protara Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.85 and a Current Ratio set at 9.85.
TARA Stock EPS
With the latest financial reports released by the company, Protara Therapeutics Inc posted -0.9/share EPS, while the average EPS was predicted by analysts to be reported at -0.92/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.02. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TARA.
Protara Therapeutics Inc [TARA] Institutonal Ownership Details
There are presently around $51.11%, or 54.45%% of TARA stock, in the hands of institutional investors. The top three institutional holders of TARA stocks are: OPALEYE MANAGEMENT INC. with ownership of 2.3 million shares, which is approximately 20.1758%. RA CAPITAL MANAGEMENT, L.P., holding 1.9 million shares of the stock with an approximate value of $$3.95 million in TARA stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$2.05 million in TARA stock with ownership which is approximately 8.6167%.
